Abstract
Introduction: Severe oligozoospermia (in vitro ubiquinone supplementation on postthaw sperm motility and viability were examined in men with severe oligozoospermia. Methods: A posttest-only control-group design was used in this laboratory study, with eight semen samples exhibiting severe oligozoospermia. The samples were evenly allocated to control (no supplementation) and treatment (100 µM ubiquinone added to the cryopreservation solution) groups. Motile spermatozoa (10–15 cells/aliquot) were selected via micromanipulation, cryopreserved in Origio™ media, and kept for 24 h. Cell motility and viability postthaw were evaluated microscopically and analyzed using paired t -tests. Results: The postthaw motility of the ubiquinone-treated samples decreased significantly (88.93% ± 7.27%) compared to the control group (98.25% ± 4.95%; P = 0.032). The viability loss in the ubiquinone group (43.50% ± 7.74%) was insignificantly lower than in the control group (47.38% ± 10.47%) ( P = 0.357). Conclusions: In males with severe oligozoospermia, ubiquinone supplementation during cryopreservation decreased postthaw motility loss in sperm, indicating the possibility of employing ubiquinone as a targeted antioxidant adjunct for fertility preservation. However, given the settings of the research, ubiquinone’s impact on cell viability was restricted. To investigate the wider therapeutic uses of ubiquinone in fertility preservation, further research is needed.

This publication has 20 references indexed in Scilit: